We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Verseon (DI) | LSE:VSN | London | Ordinary Share | COM USD0.001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 74.00 | 70.00 | 78.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMVSN
RNS Number : 4915M
Verseon Corporation
08 January 2019
January 8, 2019
Verseon Corporation
("Verseon" or the "Company")
Additional listing confirmation
Fremont, Calif.- Further to the announcements made on 27 December 2018 and 3 January 2019, Verseon announces that the aggregated 50,639 new shares of common stock ("Common Shares") of par value US $0.001 issued will be admitted to trading on January 10, 2018 ("Admission").
Total Voting Rights
Following Admission, the issued share capital of the Company will consist of 151,695,038 Common Shares and the Company will hold 42,917 shares in treasury. Therefore, the total number of Common Shares in the Company with voting rights will be 151,652,121. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
Verseon Corporation www.verseon.com +1 (510) 225 Sebastian Wykeham 9000 Arden Partners (NOMAD and Joint Broker) Ruari McGirr / Ciaran Walsh / Maria +44 (0) 20 7614 Gomez De Olea 5900 Cantor Fitzgerald Europe (Joint Broker) +44 (0) 20 7894 Phil Davies 7000
For financial and business media enquiries, please contact:
Buchanan Communications Ltd (PR Advisers) +44 (0) 20 7466 Henry Harrison-Topham / Jamie Hooper 5000
For trade and pharma media enquiries, please contact:
Vane Percy & Roberts +44 (0) 1737 Simon Vane Percy 821 890
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ALSUWAKRKWAARRR
(END) Dow Jones Newswires
January 08, 2019 07:00 ET (12:00 GMT)
1 Year Verseon Chart |
1 Month Verseon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions